Insights on the Glycogen Synthase Kinase 3 Beta Market to 2027 | Industry Statistics, Emerging Demands, Forecast to 2027The global glycogen synthase kinase 3 beta market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Glycogen synthase kinase 3, or GSK-3 refers to a serine/threonine, proline-directed kinase that is associated with a diverse array of signaling pathways, which includes cellular adhesion and glycogen synthesis. The compounds derived from natural sources come mainly from plants or marine organisms, and include Indirubin, Hymenialdisine, Meridianins, Manzamines, Palinurin, and Tricantin. Another promising opportunity for the market growth includes the favorable outcome of the glycogen synthase kinase 3 beta in the treatment of bipolar disorder. As per the Institute for Health Metrics and Evaluation (IHME), Global Burden of Diseases, the prevalence of bipolar disorder across the world varies from 0.3 to 1.2% by country. In 2017, around 46 million people around the globe had bipolar disorder, with 52% and 48% being female and male, respectively. The typical age of onset is the late teens or the early 20s, and a history of depression is common in people diagnosed with bipolar.
To Request a Sample of our Report on Glycogen Synthase Kinase 3 Beta Market: https://www.omrglobal.com/request-sample/glycogen-synthase-kinase-3-beta-market
The major factor primarily attributed to the market growth include the growing use of these inhibitors in in vivo models and in numerous clinical trials. Since 2011, substantial developments in glycogen synthase kinase 3 beta were witnessed in the form of products that include AZD1080 from AstraZeneca and LY2090314 from Eli-Lilly (both ATP competitive inhibitors). Unfortunately, their development was discontinued due to safety issues. Further, glycogen synthase kinase beta is further likely to be used in the treatment of musculoskeletal disorder, lung cancer, dyskinesia, and Menkes disease, among others.
Some key players operating in the market include AstraZeneca plc, Eli Lilly and Co., and Santa Cruz Biotechnology, Inc., among others.
· The market number available for - 2020-2027
· Base year- 2020
· Forecast period- 2021-2027
· By Type
· By Indication
· North America
· Rest of the World
Competitive Landscape: AstraZeneca plc, Eli Lilly and Co., and Santa Cruz Biotechnology, Inc., among others.
(Get 15% Discount on Buying this Report)
A full Report of Glycogen Synthase Kinase 3 Beta Market is Available @ https://www.omrglobal.com/industry-reports/glycogen-synthase-kinase-3-beta-market
Global Glycogen Synthase Kinase 3 Beta Market Report by Segment
• Musculoskeletal Disorder
• Lung Cancer
• Menkes Disease
• Inflammatory Disease
Global Glycogen Synthase Kinase 3 Beta Market Report by Region
· United States
· Rest of Europe
· South Korea
· Rest of APAC
Rest of the World
· Latin America
· Middle East & Africa
Reasons to buy from us -
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Contact no: +91 7803040404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Insights on the Glycogen Synthase Kinase 3 Beta Market to 2027 | Industry Statistics, Emerging Demands, Forecast to 2027 here
News-ID: 2578619 • Views: 172
More Releases from Orion Market Research
US Consumer Packaging Market Booming Worldwide with Latest Trend and Future Scop …
The US consumer packaging market is estimated to grow at a CAGR of 4.5% during the forecast period. Rising demand for flexible packaging across end-user industries is primarily leveraging market growth. As per the Flexible Packaging Association (FPA), in the US, the flexible packaging industry generated $31.8 billion in sales in 2018. It is the second-largest packaging segment in the country accounted for nearly 19% of the $170 billion US
North American Consumer Packaging Market Will Generate Record Revenue by 2029
North American consumer packaging market is estimated to grow at a CAGR of 3.8% during the forecast period. North American is the leader in the pharmaceutical industry, coupled with the presence of several large and small pharmaceutical firms in the region. The region is renowned for conducting massive R&D and produce bulk pharmaceuticals. As per the European Federation of Pharmaceutical Industries and Associations (EFPIA), in 2017, North American held 48.1%
European Consumer Packaging Market Comprehensive Insight by Growth Rate, Industr …
The European consumer packaging market is estimated to grow at a CAGR of 4.8% during the forecast period. Significant rise in the packaging industry and increasing pharmaceutical production are some key factors primarily contributing to market growth. As per the PlasticsEurope, in 2018, the European plastics industry generated revenue of over $413.3 billion, with a positive trade balance of over $17.2 billion. In 2018, 9.4 million tons of plastic post-consumer
Asia-Pacific Consumer Packaging Market is Anticipated to Increase at a Stable CA …
Asia-Pacific consumer packaging market is estimated to grow at a significant CAGR of 7.0% during the forecast period. The major factors contributing to the growth of the market include a significant rise in the production of food and beverage and pharmaceuticals in the region. The rising demand for processed food is one of the major causes that accelerates the demand for packaging solutions in the region. As per the India
More Releases for Glycogen
Glycogen Synthase Kinase 3 (GSK-3) Inhibitor Market 2020 Research and Clinical A …
Glycogen Synthase Kinase 3 (GSK-3) Inhibitor -Pipeline Insight, 2020 The report will make detailed analysis mainly on in-depth research on the development environment, Market size, development trend, operation situation and future development trend of Glycogen Synthase Kinase 3 (GSK-3) Inhibitor Market on the basis of stating current situation of the industry in 2020. This is a latest report, covering the current COVID-19 impact on the market. The pandemic of Coronavirus (COVID-19) has
Glycogen Metabolism Disease Market Forecast by 2025: QY Research
This recently published report examines the global Glycogen Metabolism Disease market for the projected period of 7-years, i.e. between 2018 and 2025. The report highlights the accomplishments and opportunities lies in the market throughout the forecasted period. The report offers the thorough information about the overview and the scope of the global Glycogen Metabolism Disease market along with its drivers, restraints, and trends. It also classifies the market into different
Global Glycogen Storage Disorders (GSD) Clinical Trials Market 2021 Key Company …
Qyresearchreports include new market research report "Global Glycogen Storage Disorders (GSD) Clinical Trials Sales Market Report 2021" to its huge collection of research reports. The report here assembles exchange points of view having a place with the general Glycogen Storage Disorders (GSD) Clinical Trials market which verbalizes the present-day information and future exposures with reference to the dynamic forces at play. The prime explanation for the examination report is to offer
New Research Report Offers Pipeline Review of Glycogen Synthase Kinase 3 Beta in …
GSK3B, also known as Glycogen Synthase Kinase 3 beta is basically an enzyme that is encoded by the GSK3B. It constitutively actuate protein kinase that goes about as a negative controller in the Wnt flagging, hormonal control of glucose homeostasis, and direction of interpretation elements and microtubules. According to this new research report, titled, “Glycogen Synthase Kinase 3 Beta (Serine/Threonine Protein Kinase GSK3B or GSK3B or EC 220.127.116.11 or EC 18.104.22.168)
Global Clinical Trials Review for Glycogen Storage Disorders (GSD), H2, 2017
"The Report Glycogen Storage Disorders (GSD) Global Clinical Trials Review, H2, 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" Glycogen Storage Disorders (GSD) Global Clinical Trials Review, H2, 2017 Summary GlobalDatas clinical trial report, Glycogen Storage Disorders (GSD) Global Clinical Trials Review, H2, 2017" provides an overview of Glycogen Storage Disorders (GSD) clinical trials scenario. Get Sample copy of this Report @ https://www.marketresearchreports.biz/sample/sample/1335069
Global Glycogen Storage Disorders (GSD) Clinical Trials Sales Market Report 2021
This report studies sales (consumption) of Glycogen Storage Disorders (GSD) Clinical Trials in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering Sanofi Ultragenyx Pharmaceutical Novo A/S Promethera Biosciences S.A. Baylor Reasearch Institute Asrhus University Hospital Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue,